(Q82578745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Gordon F Schwartz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jonathan E Tannebaum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Amelia M Jernigan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Juan P Palazzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1243-1251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

Sentinel lymph node in breast cancer

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Current controversies concerning sentinel lymph node biopsy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Neoadjuvant systemic therapy and the surgical management of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Recent advances in sentinel lymph node biopsy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel node biopsy prior to neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Reaping the harvest from neoadjuvant therapy for breast cancer: reducing morbidity with sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Controversies in the use of sentinel nodes: microinvasion, post surgery and after preoperative systemic treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Current controversies in sentinel lymph node biopsy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breast.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel nodes might not reflect nodal status after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Utilization of sentinel lymph node mapping to determine pathologic outcomes for patients receiving neoadjuvant chemotherapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24887

7 January 2021

Identifiers

DOI

10.1002/CNCR.24887

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20087958%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference